Inhibition of complement components C3 and C4 by cadralazine and its active metabolite

This publication has 15 references indexed in Scilit:

• Cadralazine did not produce the SLE-syndrome when hydralazine did
  European Journal of Clinical Pharmacology, 1987
• Disposition and pharmacokinetics of cadralazine and individual metabolites in man
  European Journal of Drug Metabolism and Pharmacokinetics, 1985
• DRUGS THAT INDUCE SYSTEMIC LUPUS ERYTHEMATOSUS INHIBIT COMPLEMENT COMPONENT C4
  Published by Elsevier ,1984
• Degradation of human complement component C4b in the presence of the C4b-binding protein-protein S complex
  Biochemical Journal, 1983
• Hydralazine
  New England Journal of Medicine, 1976
• DRUGS AND ???DISSEMINATED LUPUS ERYTHEMATOSUS???
  Adverse Drug Reaction Bulletin, 1973
• Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis
  The American Journal of Medicine, 1973
• Electroimmuno Assay
  Scandinavian Journal of Clinical and Laboratory Investigation, 1972
• Agarose Gel Electrophoresis
  Scandinavian Journal of Clinical and Laboratory Investigation, 1972
• GENETIC VARIATIONS IN THE ACETYLATION OF ISONIAZID AND OTHER DRUGS
  Annals of the New York Academy of Sciences, 1968